APA (7th ed.) Citation

Ueda, T., Kumagai, A., Iriguchi, S., Yasui, Y., Miyasaka, T., Nakagoshi, K., . . . Kaneko, S. (2020). Non–clinical efficacy, safety and stable clinical cell processing of induced pluripotent stem cell‐derived anti–glypican‐3 chimeric antigen receptor‐expressing natural killer/innate lymphoid cells. Cancer science, 111(5), 1478-1490. https://doi.org/10.1111/cas.14374

Chicago Style (17th ed.) Citation

Ueda, Tatsuki, et al. "Non–clinical Efficacy, Safety and Stable Clinical Cell Processing of Induced Pluripotent Stem Cell‐derived Anti–glypican‐3 Chimeric Antigen Receptor‐expressing Natural Killer/innate Lymphoid Cells." Cancer Science 111, no. 5 (2020): 1478-1490. https://doi.org/10.1111/cas.14374.

MLA (9th ed.) Citation

Ueda, Tatsuki, et al. "Non–clinical Efficacy, Safety and Stable Clinical Cell Processing of Induced Pluripotent Stem Cell‐derived Anti–glypican‐3 Chimeric Antigen Receptor‐expressing Natural Killer/innate Lymphoid Cells." Cancer Science, vol. 111, no. 5, 2020, pp. 1478-1490, https://doi.org/10.1111/cas.14374.